These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 21159829)

  • 1. Healthcare cost and loss of productivity in a Canadian population of patients with and without lupus nephritis.
    Aghdassi E; Zhang W; St-Pierre Y; Clarke AE; Morrison S; Peeva V; Landolt-Marticorena C; Su J; Reich H; Scholey J; Herzenberg A; Pope JE; Peschken C; ; Wither JE; Fortin PR
    J Rheumatol; 2011 Apr; 38(4):658-66. PubMed ID: 21159829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term medical costs and resource utilization in systemic lupus erythematosus and lupus nephritis: a five-year analysis of a large medicaid population.
    Li T; Carls GS; Panopalis P; Wang S; Gibson TB; Goetzel RZ
    Arthritis Rheum; 2009 Jun; 61(6):755-63. PubMed ID: 19479688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SLE patients with renal damage incur higher health care costs.
    Clarke AE; Panopalis P; Petri M; Manzi S; Isenberg DA; Gordon C; Senécal JL; Joseph L; St Pierre Y; Li T
    Rheumatology (Oxford); 2008 Mar; 47(3):329-33. PubMed ID: 18238790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A structured literature review of the direct costs of adult systemic lupus erythematosus in the US.
    Slawsky KA; Fernandes AW; Fusfeld L; Manzi S; Goss TF
    Arthritis Care Res (Hoboken); 2011 Sep; 63(9):1224-32. PubMed ID: 21584945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The cost of care of systemic lupus erythematosus (SLE) in the UK: annual direct costs for adult SLE patients with active autoantibody-positive disease.
    Khamashta MA; Bruce IN; Gordon C; Isenberg DA; Ateka-Barrutia O; Gayed M; Donatti C; Guillermin AL; Foo J; Perna A
    Lupus; 2014 Mar; 23(3):273-83. PubMed ID: 24356612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum albumin as a marker for disease activity in patients with systemic lupus erythematosus.
    Yip J; Aghdassi E; Su J; Lou W; Reich H; Bargman J; Scholey J; Gladman DD; Urowitz MB; Fortin PR
    J Rheumatol; 2010 Aug; 37(8):1667-72. PubMed ID: 20516026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The economic burden of systemic lupus erythematosus in Asia: the current state.
    Mak A
    Lupus; 2010 Oct; 19(12):1442-6. PubMed ID: 20947555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Direct and indirect costs to employers of patients with systemic lupus erythematosus with and without nephritis.
    Carls G; Li T; Panopalis P; Wang S; Mell AG; Gibson TB; Goetzel RZ
    J Occup Environ Med; 2009 Jan; 51(1):66-79. PubMed ID: 19136875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Economic impact of lupus.
    Clarke A
    Am J Manag Care; 2001 Oct; 7(16 Suppl):S496-501. PubMed ID: 11680782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measurement of interleukin-1 receptor antagonist in patients with systemic lupus erythematosus could predict renal manifestation of the disease.
    Brugos B; Kiss E; Dul C; Gubisch W; Szegedi G; Sipka S; Zeher M
    Hum Immunol; 2010 Sep; 71(9):874-7. PubMed ID: 20538031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical and morphological characteristics of lupus nephritis in systemic lupus erythematosus with antiphospholipid syndrome].
    Kozlovskaia NL; Shilov EM; Meteleva NA; Varshavskiĭ VA; Miroshnichenko NG; Samokishina NA; Serova AG; Nesterova SG
    Ter Arkh; 2006; 78(5):21-31. PubMed ID: 16889045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systemic lupus erythematosus with neuropsychiatric manifestation incurs high disease costs: a cost-of-illness study in Hong Kong.
    Zhu TY; Tam LS; Lee VW; Lee KK; Li EK
    Rheumatology (Oxford); 2009 May; 48(5):564-8. PubMed ID: 19269959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Economic outcomes in patients diagnosed with systemic lupus erythematosus with versus without nephritis: results from an analysis of data from a US claims database.
    Pelletier EM; Ogale S; Yu E; Brunetta P; Garg J
    Clin Ther; 2009 Nov; 31(11):2653-64. PubMed ID: 20110008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of flare on disease costs of patients with systemic lupus erythematosus.
    Zhu TY; Tam LS; Lee VW; Lee KK; Li EK
    Arthritis Rheum; 2009 Sep; 61(9):1159-67. PubMed ID: 19714597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreasing costs and improving outcomes in systemic lupus erythematosus: using regression trees to develop health policy.
    Clarke AE; Bloch DA; Danoff DS; Esdaile JM
    J Rheumatol; 1994 Dec; 21(12):2246-53. PubMed ID: 7699625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drivers of cost and health-related quality of life in patients with systemic lupus erythematosus (SLE): a Swedish nationwide study based on patient reports.
    Bexelius C; Wachtmeister K; Skare P; Jönsson L; Vollenhoven Rv
    Lupus; 2013 Jul; 22(8):793-801. PubMed ID: 23761101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medical costs and healthcare resource use in patients with lupus nephritis and neuropsychiatric lupus in an insured population.
    Furst DE; Clarke A; Fernandes AW; Bancroft T; Gajria K; Greth W; Iorga SR
    J Med Econ; 2013; 16(4):500-9. PubMed ID: 23363329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The socioeconomic burden of systemic lupus erythematosus: state-of-the-art and prospects.
    Zhu TY; Tam LS; Li EK
    Expert Rev Pharmacoecon Outcomes Res; 2012 Feb; 12(1):53-69. PubMed ID: 22280197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-neutrophil cytoplasmic antibodies (ANCA) in systemic lupus erythematosus: prevalence, clinical associations and correlation with other autoantibodies.
    Pradhan VD; Badakere SS; Bichile LS; Almeida AF
    J Assoc Physicians India; 2004 Jul; 52():533-7. PubMed ID: 15645975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Costs associated with severe and nonsevere systemic lupus erythematosus in Canada.
    Clarke AE; Urowitz MB; Monga N; Hanly JG
    Arthritis Care Res (Hoboken); 2015 Mar; 67(3):431-6. PubMed ID: 25185936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.